305 related articles for article (PubMed ID: 10485475)
1. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
3. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.
Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF
Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344
[TBL] [Abstract][Full Text] [Related]
4. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
Hirota S; Nishida T; Isozaki K; Taniguchi M; Nakamura J; Okazaki T; Kitamura Y
J Pathol; 2001 Apr; 193(4):505-10. PubMed ID: 11276010
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of gastric stromal tumors.
Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
11. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
Tang M; Li DQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
[TBL] [Abstract][Full Text] [Related]
12. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA
Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
14. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
15. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors.
Ernst SI; Hubbs AE; Przygodzki RM; Emory TS; Sobin LH; O'Leary TJ
Lab Invest; 1998 Dec; 78(12):1633-6. PubMed ID: 9881963
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic targets in gastrointestinal stromal tumors].
Wardelmann E; Schildhaus HU; Merkelbach-Bruse S; Büttner R
Verh Dtsch Ges Pathol; 2006; 90():73-9. PubMed ID: 17867582
[TBL] [Abstract][Full Text] [Related]
17. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y
J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524
[TBL] [Abstract][Full Text] [Related]
18. A recurrent duodenal gastrointestinal stromal tumor with a frameshift mutation resulting in a stop codon in KIT exon 13.
Vu HA; Xinh PT; Kikushima M; Zhu Y; Tokuhara M; Tani M; Shimizu T; Saito K; Tokunaga K; Sato Y
Genes Chromosomes Cancer; 2005 Feb; 42(2):179-83. PubMed ID: 15543597
[TBL] [Abstract][Full Text] [Related]
19. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
20. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor].
Ma D; Liu X; Cai Z; Xie Q
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]